XC

Xiaochi Capital

Asia, Zhejiang, China, Hangzhou

Description

Xiaochi Capital is an investment firm.

Investor Profile

Xiaochi Capital has backed more than 2 startups, with 0 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Seed, Series B rounds (top funding stages).
  • Majority of deals are located in China.
  • Strong thematic focus on Biopharma, Biotechnology, Life Science.

Stage Focus

  • Seed (50%)
  • Series B (50%)

Country Focus

  • China (100%)

Industry Focus

  • Biopharma
  • Biotechnology
  • Life Science
  • Manufacturing
  • Medical
  • Medical Device
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Xiaochi Capital frequently co-invest with?

GT
Asia, Fujian, China, Jiangxi
Co-Investments: 1
Hongda Capital
Asia, Shanghai, China, Shanghai
Co-Investments: 1
BeiGene
North America, Massachusetts, United States, Cambridge
Co-Investments: 1
LG
Asia, Beijing, China, Beijing
Co-Investments: 1
BM
North America, California, United States, Dublin
Co-Investments: 1
Haibang Capital
Asia, Zhejiang, China, Hangzhou
Co-Investments: 1
Yael Capital Management Limited
Asia, Guangdong, China, Shenzhen
Co-Investments: 1
Tiantu Capital
Asia, Guangdong, China, Shenzhen
Co-Investments: 1

What are some of recent deals done by Xiaochi Capital?

Recorna Bio

Guangzhou, Guangdong, China

Recorna Bio is a biotechnology company that provides research and development for RNA editing and genome modifications.

BiopharmaBiotechnologyLife Science
SeedJun 28, 2024
DECANS

Jiaxing, Zhejiang, China

DECANS manufactures orthopedic implants and surgical technology systems.

ManufacturingMedicalMedical Device
Series BFeb 21, 2022
Amount Raised: $78,922,861